Oryzon Genomics S.A. (BME:ORY)
Spain flag Spain · Delayed Price · Currency is EUR
2.802
+0.008 (0.29%)
Sep 16, 2026, 5:35 PM CET

Oryzon Genomics Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
22924591115133142
Market Cap Growth
9.02%170.69%-21.18%-13.63%-6.58%-32.20%
Enterprise Value
22523299121129124
Last Close Price
2.793.111.401.892.482.70

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-13.98106.87---
PS Ratio
14.8622.4312.318.108.4813.42
PB Ratio
1.912.081.031.411.832.00
P/TBV Ratio
1.912.081.031.411.852.02

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
14.6121.2413.408.538.1911.66

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.090.150.180.220.310.25
Net Debt / Equity Ratio
-0.03-0.090.120.070.02-0.16
Net Debt / EBITDA Ratio
0.671.90-2.42-1.36-0.231.63
Net Debt / FCF Ratio
0.784.39-1.83-10.46-0.642.95
Asset Turnover
0.110.090.070.140.160.11
Inventory Turnover
37.7984.2367.1130.808.173.55
Quick Ratio
1.591.940.740.871.343.75
Current Ratio
1.601.950.750.871.343.76
Return on Equity (ROE)
-2.08%-2.53%-4.21%-4.35%-5.88%-6.37%
Return on Assets (ROA)
-2.66%-2.81%-2.60%-2.71%-3.45%-4.63%
Return on Capital Employed (ROCE)
-4.60%-4.40%-4.60%-5.00%-6.50%-8.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1.06%-1.06%-3.95%-2.92%-3.18%-3.29%
FCF Yield
-2.18%-0.98%-6.39%-0.50%-1.44%-2.67%
Buyback Yield / Dilution
-0.01%-19.72%-6.35%-10.10%-4.80%-